2026 Q3 - tulosraportti
13 päivää sitten
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| 1 324 | ||
| 326 | ||
| 7 718 | ||
| 17 249 | ||
| 16 647 |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q4 - tulosraportti 25.2.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q3 - tulosraportti 29.10. | ||
2026 Q2 - tulosraportti 20.8. | ||
2026 Q1 - tulosraportti 7.5. | ||
2025 Q4 - tulosraportti 26.2. | ||
2025 Q3 - tulosraportti 22.10.2025 |
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
·17 t sittenI believe in it and I am down -40% so just hold onYes I am also completely calm and have bought up down here at the bottom so everything is fine
·1 päivä sittenlager status Medcanonestop the pharmacy that was sold out yesterday has got Weeco Astrum10/10 in stock again. it is from 1-2 pharmacies.Now I am repeating myself, this is very complicated material, and I have explained in detail how to understand German legislation and their healthcare system previously, several times in fact. Now I am doing it again, one last time. I cannot make it shorter unfortunately, and that is also why it is the last time I am explaining it. I am basing this on medical cannabis because it is relevant for this stock, but it applies to all prescription medicine that is reimbursable, and only that. (not when people pay out of pocket) In the first half of the year, Q1 and Q2, when everything was "normal" in Germany, doctors prescribed medical cannabis and pharmacies received the prescriptions and dispensed these to customers. I could see from the inventory that there was a high flow in stock, because it was often reported sold out, and pharmacies made sure to get the oil back in stock as quickly as possible. All was good and no dangers. This is a simplification of what happened with the legislation. But then what happened, like a thief in the night, was that on July 10, 2026, politicians initially decided to remove the reimbursement for flower medicine. However, not all doctors had seen this notification or understood it correctly, nor had the pharmacies. It got a bit messy, because the doctors who had understood the message, or whose approval field was deactivated, made sure that their patients were prescribed oil instead of flowers. (That is why many pharmacies sold out lightning fast) But the doctors who had not heard it or whose approval field was not deactivated, they continued to prescribe flower medicine. They could continue to do so because some insurance companies had forgotten, in the confusion, to deactivate the approval button. German politicians became furious that doctors and pharmacies did not fall in line and stop prescribing flower medicine and dispensing it for free to customers. Therefore, on July 30, it was announced again what the law from July 10 was about, and the approval button was deactivated so that doctors could no longer prescribe flower medicine for free. What consequences did that have for doctors and pharmacies? Now we come to the dreaded regress system. It works such that if doctors exceed their budgets, which they receive every 3 months, or if they issue prescriptions by mistake where there previously was 100% reimbursement, just like with the flower medicine, what happens is that the doctor has to pay the money back to the insurance company out of pocket, even if they have not understood the message or read it, as has been the case with the above; that is not the politicians' headache, it is the doctors'. Therefore, the doctors who had prescribed prescriptions after the legislation came into force had to pay for all the prescriptions they had written after this date out of their own pocket. Here pharmacies did not escape, because it has turned out that the pharmacies that dispensed the cannabis medicine after the aforementioned date, even if people come after this date and the prescription in principle had not expired, they were also made to pay out of pocket because the insurance companies refused to pay reimbursement for these prescriptions. As I wrote, it was very messy for after July 10 and before July 30, because many unclear clarifications came regarding how it should be interpreted, sometimes there was a quarantine and other times there was no quarantine for the oil after all. But the aforementioned and final clarification from October, where politicians have decided that the quarantine is gone, is very important for Weeco Astrum 10/10, because with this in hand, doctors and pharmacies do not risk getting caught in the regress system when the prescription is prescribed and dispensed after the final clarification in October. I could see that in the spring the oil was practically ripped off the shelves, and for a while after July 10 it also went fast, but after July 30 it sold out in a couple of days, and the pharmacies that had permission began to trade internally, i.e., from pharmacies that had a large stock. Ex the pharmacy in Hamburg. Now that the quarantine is gone, the final announcement, I can see that the fear of regress among doctors and pharmacies has disappeared completely, because prescriptions are being written anew for Weeco Astrum 10/10, and pharmacies are also dispensing Weeco Astrum 10/10 again. I can see this because a flow has returned to the inventory and pharmacies are getting the oil back in stock. It is not going as fast as it did in the spring, but as TS has said, it is getting back up to gear. This is why I think that inventory status is valuable knowledge, because it does not lie. Reimbursement system where doctors have to pay out of pocket if they do not comply with the legislation. https://www.arzt-wirtschaft.de/lexikon/arzneimittelregress Pharmacies are also covered by the dreaded regress system. https://www.abacusmedicine.com/de/retaxierung-apotheke/- ·1 päivä sittenThese new guidelines, the quarantine has ended, have been sent out to all doctors from KBV. (The Association of Statutory Health Insurance Physicians.) Briefly put, they write that doctors do not risk being punished by prescribing prescriptions for cannabis oils. This message is from October 17, and it looks like doctors have started prescribing Weeco Astrum10/10 again, because I can see that the pharmacies are starting to report sold out again. First-time prescription of cannabis: No more approval requirements for certain occupational groups https://www.kbv.de/praxis/tools-und-services/praxisnachrichten/2024/10-17/Erstverordnung%20von%20Cannabis-%20Kein%20Genehmigungsvorbehalt%20mehr%20f%C3%BCr%20bestimmte%20Fachgruppen
Impressive that KBV could already in October 2024 repeal a rule from July 2026. That probably requires more than ordinary insight into the market – almost a crystal ball - or an increased consumption of Astrum. You have of course repeatedly emphasized how complicated the legislation is. Have you considered whether it might be you yourself who has misunderstood something? - ·3 päivää sittenStock status Flowzz has gone from 2 to 1 pharmacy Weed.de has gone from 2 to 1 pharmacy CannaNow has gone from 3 to 2 pharmacies. Regarding CannaNow. After they changed their layout, it has been confusing regarding their stock holdings. I know now that they have had Weeco Astrum 10/10 in stock for quite a while. yesterday they had three pharmacies that had the oil in stock and today a smaller one. Now that pharmacies are starting to sell out again, it is a positive sign that it has broken through to the doctors, that the German politicians have finally ensured that doctors have complete clarity that the quarantine is off the table, and it is only a few diseases that need to be prescribed medicine that is approved for these diseases.
- ·5.11. · MuokattuLager status Privatrezept has sold out at 1 pharmacy Flowzs has sold out at 1 pharmacy Medcanonestop has sold out at 1 pharmacy Something has started to happen again with the sales of Weeco Astrum10/10. It supports what was said at the last webcast, that sales are starting to pick up again.
It could be interesting if 3D supplemented with a remark on how the market is receiving all these "positive" news about inventory status. I have a nasty suspicion that the market sees the news value approximately 180 degrees opposite to 3D's optimism Who is wiser? 3D or the market?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Dataa ei löytynyt
2026 Q3 - tulosraportti
13 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·17 t sittenI believe in it and I am down -40% so just hold onYes I am also completely calm and have bought up down here at the bottom so everything is fine
- ·1 päivä sittenlager status Medcanonestop the pharmacy that was sold out yesterday has got Weeco Astrum10/10 in stock again. it is from 1-2 pharmacies.Now I am repeating myself, this is very complicated material, and I have explained in detail how to understand German legislation and their healthcare system previously, several times in fact. Now I am doing it again, one last time. I cannot make it shorter unfortunately, and that is also why it is the last time I am explaining it. I am basing this on medical cannabis because it is relevant for this stock, but it applies to all prescription medicine that is reimbursable, and only that. (not when people pay out of pocket) In the first half of the year, Q1 and Q2, when everything was "normal" in Germany, doctors prescribed medical cannabis and pharmacies received the prescriptions and dispensed these to customers. I could see from the inventory that there was a high flow in stock, because it was often reported sold out, and pharmacies made sure to get the oil back in stock as quickly as possible. All was good and no dangers. This is a simplification of what happened with the legislation. But then what happened, like a thief in the night, was that on July 10, 2026, politicians initially decided to remove the reimbursement for flower medicine. However, not all doctors had seen this notification or understood it correctly, nor had the pharmacies. It got a bit messy, because the doctors who had understood the message, or whose approval field was deactivated, made sure that their patients were prescribed oil instead of flowers. (That is why many pharmacies sold out lightning fast) But the doctors who had not heard it or whose approval field was not deactivated, they continued to prescribe flower medicine. They could continue to do so because some insurance companies had forgotten, in the confusion, to deactivate the approval button. German politicians became furious that doctors and pharmacies did not fall in line and stop prescribing flower medicine and dispensing it for free to customers. Therefore, on July 30, it was announced again what the law from July 10 was about, and the approval button was deactivated so that doctors could no longer prescribe flower medicine for free. What consequences did that have for doctors and pharmacies? Now we come to the dreaded regress system. It works such that if doctors exceed their budgets, which they receive every 3 months, or if they issue prescriptions by mistake where there previously was 100% reimbursement, just like with the flower medicine, what happens is that the doctor has to pay the money back to the insurance company out of pocket, even if they have not understood the message or read it, as has been the case with the above; that is not the politicians' headache, it is the doctors'. Therefore, the doctors who had prescribed prescriptions after the legislation came into force had to pay for all the prescriptions they had written after this date out of their own pocket. Here pharmacies did not escape, because it has turned out that the pharmacies that dispensed the cannabis medicine after the aforementioned date, even if people come after this date and the prescription in principle had not expired, they were also made to pay out of pocket because the insurance companies refused to pay reimbursement for these prescriptions. As I wrote, it was very messy for after July 10 and before July 30, because many unclear clarifications came regarding how it should be interpreted, sometimes there was a quarantine and other times there was no quarantine for the oil after all. But the aforementioned and final clarification from October, where politicians have decided that the quarantine is gone, is very important for Weeco Astrum 10/10, because with this in hand, doctors and pharmacies do not risk getting caught in the regress system when the prescription is prescribed and dispensed after the final clarification in October. I could see that in the spring the oil was practically ripped off the shelves, and for a while after July 10 it also went fast, but after July 30 it sold out in a couple of days, and the pharmacies that had permission began to trade internally, i.e., from pharmacies that had a large stock. Ex the pharmacy in Hamburg. Now that the quarantine is gone, the final announcement, I can see that the fear of regress among doctors and pharmacies has disappeared completely, because prescriptions are being written anew for Weeco Astrum 10/10, and pharmacies are also dispensing Weeco Astrum 10/10 again. I can see this because a flow has returned to the inventory and pharmacies are getting the oil back in stock. It is not going as fast as it did in the spring, but as TS has said, it is getting back up to gear. This is why I think that inventory status is valuable knowledge, because it does not lie. Reimbursement system where doctors have to pay out of pocket if they do not comply with the legislation. https://www.arzt-wirtschaft.de/lexikon/arzneimittelregress Pharmacies are also covered by the dreaded regress system. https://www.abacusmedicine.com/de/retaxierung-apotheke/
- ·1 päivä sittenThese new guidelines, the quarantine has ended, have been sent out to all doctors from KBV. (The Association of Statutory Health Insurance Physicians.) Briefly put, they write that doctors do not risk being punished by prescribing prescriptions for cannabis oils. This message is from October 17, and it looks like doctors have started prescribing Weeco Astrum10/10 again, because I can see that the pharmacies are starting to report sold out again. First-time prescription of cannabis: No more approval requirements for certain occupational groups https://www.kbv.de/praxis/tools-und-services/praxisnachrichten/2024/10-17/Erstverordnung%20von%20Cannabis-%20Kein%20Genehmigungsvorbehalt%20mehr%20f%C3%BCr%20bestimmte%20FachgruppenImpressive that KBV could already in October 2024 repeal a rule from July 2026. That probably requires more than ordinary insight into the market – almost a crystal ball - or an increased consumption of Astrum. You have of course repeatedly emphasized how complicated the legislation is. Have you considered whether it might be you yourself who has misunderstood something?
- ·3 päivää sittenStock status Flowzz has gone from 2 to 1 pharmacy Weed.de has gone from 2 to 1 pharmacy CannaNow has gone from 3 to 2 pharmacies. Regarding CannaNow. After they changed their layout, it has been confusing regarding their stock holdings. I know now that they have had Weeco Astrum 10/10 in stock for quite a while. yesterday they had three pharmacies that had the oil in stock and today a smaller one. Now that pharmacies are starting to sell out again, it is a positive sign that it has broken through to the doctors, that the German politicians have finally ensured that doctors have complete clarity that the quarantine is off the table, and it is only a few diseases that need to be prescribed medicine that is approved for these diseases.
- ·5.11. · MuokattuLager status Privatrezept has sold out at 1 pharmacy Flowzs has sold out at 1 pharmacy Medcanonestop has sold out at 1 pharmacy Something has started to happen again with the sales of Weeco Astrum10/10. It supports what was said at the last webcast, that sales are starting to pick up again.It could be interesting if 3D supplemented with a remark on how the market is receiving all these "positive" news about inventory status. I have a nasty suspicion that the market sees the news value approximately 180 degrees opposite to 3D's optimism Who is wiser? 3D or the market?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| 1 324 | ||
| 326 | ||
| 7 718 | ||
| 17 249 | ||
| 16 647 |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q4 - tulosraportti 25.2.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q3 - tulosraportti 29.10. | ||
2026 Q2 - tulosraportti 20.8. | ||
2026 Q1 - tulosraportti 7.5. | ||
2025 Q4 - tulosraportti 26.2. | ||
2025 Q3 - tulosraportti 22.10.2025 |
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Dataa ei löytynyt
2026 Q3 - tulosraportti
13 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q4 - tulosraportti 25.2.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q3 - tulosraportti 29.10. | ||
2026 Q2 - tulosraportti 20.8. | ||
2026 Q1 - tulosraportti 7.5. | ||
2025 Q4 - tulosraportti 26.2. | ||
2025 Q3 - tulosraportti 22.10.2025 |
Tuotteita joiden kohde-etuutena tämä arvopaperi
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·17 t sittenI believe in it and I am down -40% so just hold onYes I am also completely calm and have bought up down here at the bottom so everything is fine
- ·1 päivä sittenlager status Medcanonestop the pharmacy that was sold out yesterday has got Weeco Astrum10/10 in stock again. it is from 1-2 pharmacies.Now I am repeating myself, this is very complicated material, and I have explained in detail how to understand German legislation and their healthcare system previously, several times in fact. Now I am doing it again, one last time. I cannot make it shorter unfortunately, and that is also why it is the last time I am explaining it. I am basing this on medical cannabis because it is relevant for this stock, but it applies to all prescription medicine that is reimbursable, and only that. (not when people pay out of pocket) In the first half of the year, Q1 and Q2, when everything was "normal" in Germany, doctors prescribed medical cannabis and pharmacies received the prescriptions and dispensed these to customers. I could see from the inventory that there was a high flow in stock, because it was often reported sold out, and pharmacies made sure to get the oil back in stock as quickly as possible. All was good and no dangers. This is a simplification of what happened with the legislation. But then what happened, like a thief in the night, was that on July 10, 2026, politicians initially decided to remove the reimbursement for flower medicine. However, not all doctors had seen this notification or understood it correctly, nor had the pharmacies. It got a bit messy, because the doctors who had understood the message, or whose approval field was deactivated, made sure that their patients were prescribed oil instead of flowers. (That is why many pharmacies sold out lightning fast) But the doctors who had not heard it or whose approval field was not deactivated, they continued to prescribe flower medicine. They could continue to do so because some insurance companies had forgotten, in the confusion, to deactivate the approval button. German politicians became furious that doctors and pharmacies did not fall in line and stop prescribing flower medicine and dispensing it for free to customers. Therefore, on July 30, it was announced again what the law from July 10 was about, and the approval button was deactivated so that doctors could no longer prescribe flower medicine for free. What consequences did that have for doctors and pharmacies? Now we come to the dreaded regress system. It works such that if doctors exceed their budgets, which they receive every 3 months, or if they issue prescriptions by mistake where there previously was 100% reimbursement, just like with the flower medicine, what happens is that the doctor has to pay the money back to the insurance company out of pocket, even if they have not understood the message or read it, as has been the case with the above; that is not the politicians' headache, it is the doctors'. Therefore, the doctors who had prescribed prescriptions after the legislation came into force had to pay for all the prescriptions they had written after this date out of their own pocket. Here pharmacies did not escape, because it has turned out that the pharmacies that dispensed the cannabis medicine after the aforementioned date, even if people come after this date and the prescription in principle had not expired, they were also made to pay out of pocket because the insurance companies refused to pay reimbursement for these prescriptions. As I wrote, it was very messy for after July 10 and before July 30, because many unclear clarifications came regarding how it should be interpreted, sometimes there was a quarantine and other times there was no quarantine for the oil after all. But the aforementioned and final clarification from October, where politicians have decided that the quarantine is gone, is very important for Weeco Astrum 10/10, because with this in hand, doctors and pharmacies do not risk getting caught in the regress system when the prescription is prescribed and dispensed after the final clarification in October. I could see that in the spring the oil was practically ripped off the shelves, and for a while after July 10 it also went fast, but after July 30 it sold out in a couple of days, and the pharmacies that had permission began to trade internally, i.e., from pharmacies that had a large stock. Ex the pharmacy in Hamburg. Now that the quarantine is gone, the final announcement, I can see that the fear of regress among doctors and pharmacies has disappeared completely, because prescriptions are being written anew for Weeco Astrum 10/10, and pharmacies are also dispensing Weeco Astrum 10/10 again. I can see this because a flow has returned to the inventory and pharmacies are getting the oil back in stock. It is not going as fast as it did in the spring, but as TS has said, it is getting back up to gear. This is why I think that inventory status is valuable knowledge, because it does not lie. Reimbursement system where doctors have to pay out of pocket if they do not comply with the legislation. https://www.arzt-wirtschaft.de/lexikon/arzneimittelregress Pharmacies are also covered by the dreaded regress system. https://www.abacusmedicine.com/de/retaxierung-apotheke/
- ·1 päivä sittenThese new guidelines, the quarantine has ended, have been sent out to all doctors from KBV. (The Association of Statutory Health Insurance Physicians.) Briefly put, they write that doctors do not risk being punished by prescribing prescriptions for cannabis oils. This message is from October 17, and it looks like doctors have started prescribing Weeco Astrum10/10 again, because I can see that the pharmacies are starting to report sold out again. First-time prescription of cannabis: No more approval requirements for certain occupational groups https://www.kbv.de/praxis/tools-und-services/praxisnachrichten/2024/10-17/Erstverordnung%20von%20Cannabis-%20Kein%20Genehmigungsvorbehalt%20mehr%20f%C3%BCr%20bestimmte%20FachgruppenImpressive that KBV could already in October 2024 repeal a rule from July 2026. That probably requires more than ordinary insight into the market – almost a crystal ball - or an increased consumption of Astrum. You have of course repeatedly emphasized how complicated the legislation is. Have you considered whether it might be you yourself who has misunderstood something?
- ·3 päivää sittenStock status Flowzz has gone from 2 to 1 pharmacy Weed.de has gone from 2 to 1 pharmacy CannaNow has gone from 3 to 2 pharmacies. Regarding CannaNow. After they changed their layout, it has been confusing regarding their stock holdings. I know now that they have had Weeco Astrum 10/10 in stock for quite a while. yesterday they had three pharmacies that had the oil in stock and today a smaller one. Now that pharmacies are starting to sell out again, it is a positive sign that it has broken through to the doctors, that the German politicians have finally ensured that doctors have complete clarity that the quarantine is off the table, and it is only a few diseases that need to be prescribed medicine that is approved for these diseases.
- ·5.11. · MuokattuLager status Privatrezept has sold out at 1 pharmacy Flowzs has sold out at 1 pharmacy Medcanonestop has sold out at 1 pharmacy Something has started to happen again with the sales of Weeco Astrum10/10. It supports what was said at the last webcast, that sales are starting to pick up again.It could be interesting if 3D supplemented with a remark on how the market is receiving all these "positive" news about inventory status. I have a nasty suspicion that the market sees the news value approximately 180 degrees opposite to 3D's optimism Who is wiser? 3D or the market?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| 1 324 | ||
| 326 | ||
| 7 718 | ||
| 17 249 | ||
| 16 647 |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Välittäjätilasto
Dataa ei löytynyt